Stay updated on Nivolumab in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Advanced NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:27:33.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study details related to Nivolumab in Advanced Non-Small Cell Lung Cancer patients, specifically in terms of clinical benefit and treatment outcomes.
    Difference
    0.1%
    Check dated 2024-06-06T14:32:33.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information about eligibility criteria for clinical trial participants, including examples and a link for more information. The new criteria specify that participants must have histologically confirmed locally advanced or stage IV NSCLC.
    Difference
    6%
    Check dated 2024-05-22T21:00:03.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    0.8%
    Check dated 2024-05-01T17:58:13.000Z thumbnail image

Stay in the know with updates to Nivolumab in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced NSCLC Clinical Trial page.